SCHEMBL803844

SCHEMBL803844

CN(C(=O)OC(C)(C)C)C1CCN(C(=O)CCN2CCCCC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.45
HPGD P15428 1/20 0.39
ALDH1A1 P00352 4/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
CTSD P07339 1/20 0.35
CTSL P07711 1/20 0.35
CTSB P07858 1/20 0.35
CTSS P25774 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EPHX1 P07099 1/20 0.34
TSHR P16473 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
USP30 Q70CQ3 1/20 0.34
LSS P48449 1/20 0.34
SPR P35270 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785756 0.82 ALDH1A1 (0.41) HSD11B1ALDH1A1POLBMAPTL3MBTL1
SCHEMBL27313904 0.79 HSD11B1 (0.50) HSD11B1ALDH1A1POLBCTSDCTSL
SCHEMBL20744999 0.77 HSD11B1 (0.44) HSD11B1
SCHEMBL26666679 0.76 HSD11B1 (0.54) HSD11B1HPGDUSP30SPR
SCHEMBL29133796 0.76 HSD11B1 (0.54) HSD11B1HPGDUSP30SPRMEN1
SCHEMBL14450362 0.76 HSD11B1 (0.44) HSD11B1EPHX1
SCHEMBL21871399 0.76 HSD11B1 (0.44) HSD11B1
SCHEMBL8912028 0.75 HSD11B1 (0.50) HSD11B1ALDH1A1POLBMAPTUSP30
SCHEMBL24684941 0.74 HSD11B1 (0.56) HSD11B1HPGDUSP30SPRMEN1
SCHEMBL2053864 0.74 HSD11B1 (0.47) HSD11B1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2857388-A1 Azoles containing sulfone Grünenthal GmbH (DE) 2015-04-08 EP disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
WO-2012038081-A1 SUBSTITUTED BENZAMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-03-29 WO disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 HSD11B1 4053/4885HPGD 1082/4885ALDH1A1 1267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.